{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:54:56Z","timestamp":1782514496562,"version":"3.54.5"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>People with childbearing capacity who are diagnosed with systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS) have specific and important reproductive health considerations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recommendations from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) provide rheumatologists and other clinicians with guidance for reproductive health management of patients with rheumatic diseases. Patient-centered reproductive health counseling can help clinicians to operationalize the EULAR and ACR guidelines and enhance patient care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Disease activity monitoring, risk factor stratification, and prescription of pregnancy-compatible medications during pregnancy help to anticipate complications and enhance pregnancy outcomes in SLE and SS. Assisted reproductive technologies are also safe among people with well-controlled disease. Safe and effective contraceptive methods are available for patients with SLE and SS, and pregnancy termination appears to be safe among these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000839","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T13:15:25Z","timestamp":1631625325000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Optimizing reproductive health management in lupus and Sjogren's syndrome"],"prefix":"10.1097","volume":"33","author":[{"given":"Mehret","family":"Birru Talabi","sequence":"first","affiliation":[{"name":"Center for Women's Health Research and Innovation (CWHRI)"},{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Himes","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.B.","family":"Clowse","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Immunology, Department of Medicine, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"127e1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.semarthrit.2020.01.014","article-title":"Maternal and perinatal outcomes of pregnancies in systemic lupus erythematosus: a nationwide population-based study","volume":"50","author":"Chen","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"e000020","DOI":"10.1136\/lupus-2014-000020","article-title":"Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls","volume":"1","author":"Barnado","year":"2014","journal-title":"Lupus Sci Med"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10067-019-04823-8","article-title":"Preeclampsia in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis","volume":"39","author":"Dong","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R10-20250526","article-title":"Pregnancy outcomes in undifferentiated connective tissue disease compared to systemic lupus erythematosus: a single academic center's experience","author":"Kaufman","year":"2021","journal-title":"Arthritis Care Res"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0961203308090027","article-title":"Lupus and pregnancy: ten questions and some answers","volume":"17","author":"Ruiz-Irastorza","year":"2008","journal-title":"Lupus"},{"key":"R12-20250526","first-page":"keab155","article-title":"Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study","author":"Tani","year":"2021","journal-title":"Rheumatology"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/M19-0120","article-title":"Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis","volume":"171","author":"Mehta","year":"2019","journal-title":"Ann Intern Med"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0961203317749046","article-title":"Trends in use of hydroxychloroquine during pregnancy in Systemic lupus erythematosus patients from 2001 to 2015","volume":"27","author":"Bermas","year":"2018","journal-title":"Lupus"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/jwh.2020.8882","article-title":"Social and structural determinants of health inequities in maternal health","volume":"30","author":"Crear-Perry","year":"2021","journal-title":"J Womens Health"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/acr.23263","article-title":"Contribution of socioeconomic status to racial\/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus","volume":"70","author":"Kaplowitz","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/acr.22847","article-title":"Racial and ethnic disparities in the pregnancies of women with systemic lupus erythematosus","volume":"68","author":"Clowse","year":"2016","journal-title":"Arthritis Care Res"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.autrev.2018.08.008","article-title":"Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies","volume":"18","author":"Andreoli","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-med-042915-102658","article-title":"Management of systemic lupus erythematosus during pregnancy","volume":"68","author":"Sammaritano","year":"2017","journal-title":"Annu Rev Med"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rdc.2007.01.003","article-title":"The Hopkins Lupus Pregnancy Center: ten key issues in management","volume":"33","author":"Petri","year":"2007","journal-title":"Rheum Dis Clin N Am"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40738-015-0004-3","article-title":"Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus","volume":"1","author":"Bermas","year":"2015","journal-title":"Fertil Res Pract"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-047","article-title":"Sjogren syndrome and pregnancy: a literature review","volume":"21","author":"Gupta","year":"2017","journal-title":"Perm J"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sjogren's syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0037-1602243","article-title":"Interstitial lung disease in women of child-bearing age","volume":"38","author":"Mylvaganam","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/art.1780360911","article-title":"Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A\/Ro and anti-SS-B\/La antibodies","volume":"36","author":"Buyon","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.autrev.2017.07.013","article-title":"Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA\/Ro and SSB\/La to U1RNP","volume":"16","author":"Izmirly","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multiracial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids?","volume":"16","author":"Brucato","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"(suppl_5)","key":"R35-20250526","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/rheumatology\/key141","article-title":"The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices","volume":"57","author":"Clowse","year":"2018","journal-title":"Rheumatology"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/09612033211007199","article-title":"Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis","volume":"30","author":"Duan","year":"2021","journal-title":"Lupus"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"290e1","DOI":"10.1016\/j.ajog.2020.09.007","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bcp.12872","article-title":"Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis","volume":"81","author":"Kaplan","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203314540353","article-title":"Tacrolimus is an effective treatment for lupus nephritis in pregnancy","volume":"23","author":"Webster","year":"2014","journal-title":"Lupus"},{"key":"R43-20250526","first-page":"e44","article-title":"ACOG Committee Opinion No. 743. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1177\/0961203318787032","article-title":"Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome","volume":"27","author":"Yelnik","year":"2018","journal-title":"Lupus"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"rkaa074","DOI":"10.1093\/rap\/rkaa074","article-title":"Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series","volume":"5","author":"Perrotta","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.reprotox.2009.07.002","article-title":"Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator","volume":"28","author":"Auyeung-Kim","year":"2009","journal-title":"Reprod Toxicol"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.contraception.2019.03.046","article-title":"Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis","volume":"100","author":"Gomez","year":"2019","journal-title":"Contraception"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203315622824","article-title":"Prevalence of premature ovarian failure in patients with systemic lupus erythematosus","volume":"25","author":"Mayorga","year":"2016","journal-title":"Lupus"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0961203312468624","article-title":"The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease","volume":"22","author":"Harward","year":"2013","journal-title":"Lupus"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2019.10.002","article-title":"Assisted reproductive technologies for women with rheumatic AID","volume":"64","author":"Lockshin","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/art.1780400504","article-title":"Oral contraceptives and systemic lupus erythematosus","volume":"40","author":"Petri","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R55-20250526","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.contraception.2020.11.001","article-title":"Contraception decision-making and care among reproductive-aged women with autoimmune diseases","volume":"103","author":"Stransky","year":"2021","journal-title":"Contraception"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.41249","article-title":"Elective termination of pregnancy in autoimmune rheumatic diseases: experience from two databases","volume":"72","author":"Lockshin","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/acr.23267","article-title":"Family planning counseling for women with rheumatic diseases","volume":"70","author":"Birru Talabi","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/acr.24249","article-title":"Exploring the preferences of women regarding sexual and reproductive healthcare in the rheumatology context: a qualitative study","volume":"73","author":"Wolgemuth","year":"2021","journal-title":"Arthritis Care Res"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.23712","article-title":"Risk of unintended pregnancy among women with systemic lupus erythematosus","volume":"59","author":"Schwarz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0961203321989803","article-title":"The importance of pregnancy planning in lupus pregnancies","volume":"30","author":"Rajendran","year":"2021","journal-title":"Lupus"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"e023849","DOI":"10.1136\/bmjopen-2018-023849","article-title":"Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study","volume":"9","author":"Wu","year":"2019","journal-title":"BMJ Open"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.contraception.2014.09.014","article-title":"It just happens\u2019: a qualitative study exploring low-income women's perspectives on pregnancy intention and planning","volume":"91","author":"Borrero","year":"2015","journal-title":"Contraception"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1363\/psrh.12017","article-title":"Contraceptive Failure in the United States: Estimates from the 2006\u20132010 National Survey of Family Growth","volume":"49","author":"Sundaram","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"key":"R66-20250526","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:15Z","timestamp":1748296815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000839","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}